True opel,
I always enjoy the transparency exhibited by management when it comes to outlook, delays and details in regards to sector being pursued for a deal.
There are many other biotech companies on the ASX which could learn a lot from our management.
Just typical consolidation going on at the moment with 2 low volume days, now followed by increasing interest yet again, which possibly precede the next wave of buying.
We saw 3 consolidation days after last spike, it appears we move on like textbook from here.
interesting bidding, page-86
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.3¢ |
Change
-0.001(4.17%) |
Mkt cap ! $56.77M | |||
| Open | High | Low | Value | Volume |
| 2.3¢ | 2.4¢ | 2.2¢ | $35.45K | 1.542M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 272245 | 2.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.4¢ | 938511 | 3 |
View Market Depth
| Last trade - 15.45pm 12/09/2024 (20 minute delay) ? |
| ADO (ASX) Chart |